Ghorashian, S., Jacoby, E., De Moerloose, B., Rives, S., Bonney, D., Shenton, G., Bader, P., Bodmer, N., Quintana, A. M., Herrero, B., Algeri, M., Locatelli, F., Vettenranta, K., Gonzalez, B., Attarbaschi, A., Harris, S., Bourquin, J. P., & Baruchel, A. (2022). tisagenlecleucel therapy for relapsed or refractory B-cell acute lymphoblastic leukaemia in infants and children younger than 3 years of age at screening: an international, multicentre, retrospective cohort study. Lancet, 9(10), e766–e775. http://access.bl.uk/ark:/81055/vdc_100166747924.0x000005